SCHEMBL6013547

SCHEMBL6013547

C=C(NC)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24325518 0.74
SCHEMBL14327011 0.73
SCHEMBL23108276 0.71
SCHEMBL19200012 0.69
SCHEMBL19271952 0.69
SCHEMBL18373487 0.69
SCHEMBL21278095 0.67
SCHEMBL27062416 0.67
SCHEMBL13774854 0.66
SCHEMBL20003249 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240224783-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-07-04 US disclosed
US-20230202977-A1 CYCLIC LIPIDS AND METHODS OF USE THEREOF RENAGADE THERAPEUTICS MANAGEMENT INC. 2023-06-29 US disclosed
EP-3724191-B9 5-(2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)-3-(1H-PYRAZOL-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS AS TRK KINASE INHIBITORS FOR TREATING CANCER PYRAMID BIOSCIENCES INC (US) 2022-05-18 EP disclosed
EP-3643729-A1 AQUEOUS EMULSION AND ADHESIVE USING SAME Kuraray Co., Ltd. (JP) 2020-04-29 EP disclosed
EP-3368632-B1 POLYISOCYANURATE BASED CEMENT FOR WELLBORE FLUID LOSS PREVENTION COVESTRO LLC (US) 2020-01-29 EP disclosed
US-20190106386-A1 AZIRIDINYL CONTAINING COMPOUNDS AND METHODS OF INACTIVATING NUCLEIC ACID MOLECULES USING THE SAME NEW YORK BLOOD CENTER, INC. 2019-04-11 US disclosed
US-10173976-B2 Aziridinyl containing compounds and methods of inactivating nucleic acid molecules using the same ZATA PHARMACEUTICALS, INC. (US) 2019-01-08 US disclosed
US-9766547-B2 Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, method of manufacturing electronic device using the same, and electronic device FUJIFILM CORPORATION (JP) 2017-09-19 US disclosed
US-9760003-B2 Pattern forming method and actinic-ray- or radiation-sensitive resin composition FUJIFILM CORPORATION (JP) 2017-09-12 US disclosed
EP-2602244-B1 (Meth) Acrylic acid ester, activation energy ray curing composition, and inkjet recording ink RICOH CO LTD (JP) 2017-07-26 EP disclosed
US-20130084438-A1 PATTERN FORMING METHOD, ELECTRON BEAM-SENSITIVE OR EXTREME ULTRAVIOLET-SENSITIVE COMPOSITION, RESIST FILM, MANUFACTURING METHOD OF ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2013-04-04 US disclosed
US-20110306782-A1 New Catalytic System for Cross-Coupling Reactions CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) 2011-12-15 US disclosed
US-7919493-B2 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent PHARMA MAR, S.A. (ES) 2011-04-05 US disclosed
US-20110053873-A1 HSP90 INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-03-03 US disclosed
US-20110034449-A1 N-SUBSTITUTED HYDROXYPYRIMIDINONE CARBOXAMIDE INHIBITORS OF HIV INTEGRASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-02-10 US disclosed
US-20090029221-A1 FUNCTIONAL ANCHORS CONNECTING GRAPHENE-LIKE CARBON TO METAL NATIONAL SCIENCE FOUNDATION 2009-01-29 US disclosed
WO-2007086745-A1 PROCESS FOR THE PRODUCTION OF PHOSPHOROUS COMPOUNDS ENGELHARD DE MEERN B.V. (NL) 2007-08-02 WO disclosed
US-20070099938-A1 Antistress drug and medical use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-03 US disclosed
EP-1667962-A1 AMINOALKYLAMIDE SUBSTITUTED CYCLOHEXYL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-06-14 EP disclosed
WO-2005028427-A1 AMINOALKYLAMIDE SUBSTITUTED CYCLOHEXYL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-03-31 WO disclosed